Crossing
Innovative
Technologies
Challenging to cure intractable diseases with genome editing and iPS cell technology.

Mission

Expanding Medical Frontiers by
Crossing Innovative Technologies

iXgene is relentlessly advancing every day to deliver innovative therapies worldside.

The world that iXgene envisions

iXgene is relentlessly advancing every day to deliver innovative therapies worldwide

The world that iXgene envisions

News

2024.09.02
Announcement
We moved our office.
2024.02.09
Announcement
iXgene Inc. signs License Agreement with Keio University Educational Corporation for Commercialization of Suicide Gene Transfer iPS Cell Patents
2023.10.10
Press Release
Announcement of a three-way joint research agreement between iXgene, Keio University School of Medicine, and Sumitomo Pharma for the practical application of a treatment for malignant brain tumors using genome-edited iPS cells.
Read more

Technology

Our therapeutic cells with high efficacy, safety, and productivity

Toward Resolving the Challenges of Regenerative Medicine and Gene Therapy We start first with gene cell therapy for recurrent brain tumors.

Technology Page

About Us

We are growing our business through science and management, based on joint research with Keio University and pharmaceutical companies.